168 related articles for article (PubMed ID: 27641331)
1. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
Paul PJ; Raghu D; Chan AL; Gulati T; Lambeth L; Takano E; Herold MJ; Hagekyriakou J; Vessella RL; Fedele C; Shackleton M; Williams ED; Fox S; Williams S; Haupt S; Gamell C; Haupt Y
Oncogene; 2016 Dec; 35(48):6235-6245. PubMed ID: 27641331
[TBL] [Abstract][Full Text] [Related]
2. E6AP promotes prostate cancer by reducing p27 expression.
Raghu D; Paul PJ; Gulati T; Deb S; Khoo C; Russo A; Gallo E; Blandino G; Chan AL; Takano E; Sandhu SK; Fox SB; Williams S; Haupt S; Gamell C; Haupt Y
Oncotarget; 2017 Jun; 8(26):42939-42948. PubMed ID: 28477016
[TBL] [Abstract][Full Text] [Related]
3. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
4. Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.
Birch SE; Kench JG; Takano E; Chan P; Chan AL; Chiam K; Veillard AS; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB
Ann Oncol; 2014 Dec; 25(12):2392-2397. PubMed ID: 25231954
[TBL] [Abstract][Full Text] [Related]
5. Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Gulati T; Huang C; Caramia F; Raghu D; Paul PJ; Goode RJA; Keam SP; Williams SG; Haupt S; Kleifeld O; Schittenhelm RB; Gamell C; Haupt Y
Mol Cell Proteomics; 2018 Jun; 17(6):1170-1183. PubMed ID: 29463595
[TBL] [Abstract][Full Text] [Related]
6. E6AP promotes the degradation of the PML tumor suppressor.
Louria-Hayon I; Alsheich-Bartok O; Levav-Cohen Y; Silberman I; Berger M; Grossman T; Matentzoglu K; Jiang YH; Muller S; Scheffner M; Haupt S; Haupt Y
Cell Death Differ; 2009 Aug; 16(8):1156-66. PubMed ID: 19325566
[TBL] [Abstract][Full Text] [Related]
7. E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts.
Levav-Cohen Y; Wolyniec K; Alsheich-Bartok O; Chan AL; Woods SJ; Jiang YH; Haupt S; Haupt Y
Oncogene; 2012 Apr; 31(17):2199-209. PubMed ID: 21927031
[TBL] [Abstract][Full Text] [Related]
8. A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence.
Acevedo M; Vernier M; Mignacca L; Lessard F; Huot G; Moiseeva O; Bourdeau V; Ferbeyre G
Cancer Res; 2016 Jun; 76(11):3252-64. PubMed ID: 27206849
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.
Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y
Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802
[TBL] [Abstract][Full Text] [Related]
10. The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress.
Wolyniec K; Levav-Cohen Y; Jiang YH; Haupt S; Haupt Y
Oncogene; 2013 Jul; 32(30):3510-9. PubMed ID: 22986523
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
13. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
[TBL] [Abstract][Full Text] [Related]
14. The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Mansour M; Haupt S; Chan AL; Godde N; Rizzitelli A; Loi S; Caramia F; Deb S; Takano EA; Bishton M; Johnstone C; Monahan B; Levav-Cohen Y; Jiang YH; Yap AS; Fox S; Bernard O; Anderson R; Haupt Y
Cancer Res; 2016 Jul; 76(14):4236-48. PubMed ID: 27231202
[TBL] [Abstract][Full Text] [Related]
15. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
16. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.
Kapoor I; Kanaujiya J; Kumar Y; Thota JR; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Oncotarget; 2016 Feb; 7(7):7640-56. PubMed ID: 26506232
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
Chen C; Sun X; Guo P; Dong XY; Sethi P; Zhou W; Zhou Z; Petros J; Frierson HF; Vessella RL; Atfi A; Dong JT
Oncogene; 2007 Apr; 26(16):2386-94. PubMed ID: 17016436
[TBL] [Abstract][Full Text] [Related]
18. E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes.
Kim Y; Cairns MJ; Marouga R; Sun LQ
Cancer Gene Ther; 2003 Sep; 10(9):707-16. PubMed ID: 12944990
[TBL] [Abstract][Full Text] [Related]
19. E6AP ubiquitin ligase mediates ubiquitin-dependent degradation of peroxiredoxin 1.
Nasu J; Murakami K; Miyagawa S; Yamashita R; Ichimura T; Wakita T; Hotta H; Miyamura T; Suzuki T; Satoh T; Shoji I
J Cell Biochem; 2010 Oct; 111(3):676-85. PubMed ID: 20589759
[TBL] [Abstract][Full Text] [Related]
20. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
